The objective of this study was to evaluate the effect of hypertension
on the use of thrombolytic therapy in patients with occluded syntheti
c peripheral bypass grafts, Thrombolysis with urokinase was performed
in 44 cases of occluded lower extremity bypass grafts, The cases were
divided into two groups: Group I consisted of patients currently being
treated for hypertension, Group II consisted of patients without a hi
story of hypertension, A comparison of pre- or intra-lytic data reveal
ed that there was no significant difference in each group, Complicatio
ns occurred in 15 (32.6%) out of 46 cases, There was no significant in
crease in complication when the risk factors were compared, In Group I
, the one, two, and three year patency rates were 42.7%, 23.0%, and 7.
7% and the limb salvage rates were 93.3%, 73.9%, and 73.9% for one, tw
o, and three years respectively, The Group II patency rates were 70.6%
, 41.6%, and 41.6% and the limb salvage rates were 94.1%, 86.9%, and 8
6.9%. The patency rate was significantly reduced when Group I was comp
ared to Group II (p<0.05), There was no statistically significant diff
erence in limb salvage rates between Groups I and II, In conclusion, h
ypertension is one of the important risk factors that reduce the paten
cy rate after thrombolytic therapy in patients with peripheral arteria
l bypass graft.